Most cited article: Drug Targeting and Conventional Treatment of Multiple...
Author(s): Christina Tran, Eden Park, Pedro L. Rodriguez Flores and Robert B. Campbell* Abstract: Extensive studies have explored potential therapies against multiple myeloma (MM), whether in...
View ArticleMost cited article: Overview of Drug Therapy of COVID-19 with Safety and the...
Author(s):Rajesh Basnet*, Sandhya Khadka, Buddha Bahadur Basnet, Til Bahadur Basnet and Sanjeep Sapkota Abstract: The discovery and development of the drug/vaccine for Coronavirus Disease 2019...
View ArticleMost cited article: Electrospun Chitosan Nanofibres and its Application
Author(s):Pradnya Palekar-Shanbhag*, Amruta Dalal, Tejaswini Navale and Ujala Mishra Abstract: Chitosan is a biopolymer that has been widely used in medical, pharmaceutical, agricultural, cosmetics,...
View ArticleDrug repurposing: What is it and what does it mean for modern drug development?
Drug repurposing (also known as drug repositioning or DR) is a strategy for discovering new uses for FDA approved and investigational drugs. It is therefore, an effective process for identifying new...
View ArticleGlobal warming and climate change – a brief explanation
Our planet is artificially warming because of the greenhouse gases we are spewing into our air. When we burn fossil fuels, such as coal, oil, and natural gas, we also inadvertently produce CO2, a...
View ArticleAI: From Early Expert Systems to Mainstream AI Chatbots
Back in 2015, a foundation had been laid by the founders of Open AI with a goal to promote a more preferable quality of life. Artificial Intelligence has been playing an integral part with in our...
View ArticleAffective Computing: The Future of Human-Computer Interaction
Affective computing is a field of study that focuses on creating systems and devices that can recognize, interpret, and respond to human emotions. It involves the use of artificial intelligence and...
View ArticleMilestone: Dr. Robert C. Gallo and the Discovery of HIV-1
An interview by Dr. Paolo Lusso National Institutes of Health (NIH), Bethesda, MD, USA In this issue of the journal, we inaugurate a new series entitled “Milestones”. This series will encompass...
View ArticleEditorial Letter 1, 2 (2024): Basis and Trends for Prototyping new Nanomaterials
Author(s): A. Guillermo Bracamonte et al. Letter: In this brief communication it is intended to highlight why it is important the prototyping of Nanomaterials in the design and synthesis of new...
View ArticleEditorial Cover, 1 (2024): Nanophotonics for Advanced Optics
Insights from the design and creation towards Advances within Optical active materials A.Guillermo Bracamonte et al. Editions About the Cover In Progress. Commentary focusing light on the control of...
View Article